Literature DB >> 34453841

Prioritizing Cancer Patients for Vaccination in India.

Aparna Gangopadhyay1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34453841      PMCID： PMC8826504          DOI： 10.1093/jnci/djab176

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   11.816


× No keyword cloud information.
  5 in total

1.  Estimating COVID-19‒ Related Mortality in India: An Epidemiological Challenge With Insufficient Data.

Authors:  Lauren V Zimmermann; Maxwell Salvatore; Giridhara R Babu; Bhramar Mukherjee
Journal:  Am J Public Health       Date:  2021-07       Impact factor: 9.308

2.  Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.

Authors:  Leticia Monin; Adam G Laing; Miguel Muñoz-Ruiz; Duncan R McKenzie; Irene Del Molino Del Barrio; Thanussuyah Alaguthurai; Clara Domingo-Vila; Thomas S Hayday; Carl Graham; Jeffrey Seow; Sultan Abdul-Jawad; Shraddha Kamdar; Elizabeth Harvey-Jones; Rosalind Graham; Jack Cooper; Muhammad Khan; Jennifer Vidler; Helen Kakkassery; Shubhankar Sinha; Richard Davis; Liane Dupont; Isaac Francos Quijorna; Charlotte O'Brien-Gore; Puay Ling Lee; Josephine Eum; Maria Conde Poole; Magdalene Joseph; Daniel Davies; Yin Wu; Angela Swampillai; Bernard V North; Ana Montes; Mark Harries; Anne Rigg; James Spicer; Michael H Malim; Paul Fields; Piers Patten; Francesca Di Rosa; Sophie Papa; Timothy Tree; Katie J Doores; Adrian C Hayday; Sheeba Irshad
Journal:  Lancet Oncol       Date:  2021-04-27       Impact factor: 41.316

3.  Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout.

Authors:  Abhishek Pandey; Pratha Sah; Seyed M Moghadas; Sandip Mandal; Sandip Banerjee; Peter J Hotez; Alison P Galvani
Journal:  J Glob Health       Date:  2021-06-26       Impact factor: 4.413

4.  Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer.

Authors:  Tal Goshen-Lago; Ithai Waldhorn; Roy Holland; Moran Szwarcwort-Cohen; Anat Reiner-Benaim; Yael Shachor-Meyouhas; Khetam Hussein; Liana Fahoum; Mali Baruch; Avivit Peer; Yoram Reiter; Ronit Almog; Michael Halberthal; Irit Ben-Aharon
Journal:  JAMA Oncol       Date:  2021-07-08       Impact factor: 31.777
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.